Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06395389 · ClinicalTrials.gov registry record · NA
A Brief Intervention for Cannabis Use
A NA study of Cannabis Use Disorder, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT06395389: Recruiting NA study of Cannabis Use Disorder, sponsored by Medical University of South Carolina.
NCT06395389 is a NA study of Cannabis Use Disorder that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 62 participants, below the 107-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06395389, a NA study of Cannabis Use Disorder, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two brief interventions targeting potentially problematic cannabis use in emerging adults (ages 18-25). Brief interventions are two 40-50 minute sessions separated by 1 week. Eligible emerging adults will complete a detailed cannabis assessment (biological and self-report), followed by one of the two brief interventions, and three follow-up assessments: one immediately after the second session and at 1- and 3-months post-intervention. Assignment to the brief intervention is random. Salivary samples will be collected at baseline, post-intervention, and both follow-ups, for a total of 4 samples, to be tested for tetrahydrocannabinol (THC) and cannabidiol (CBD).
Primary Outcome
The TLFB is a calendar based assessment that is able to capture the frequency and quantity of substance use and other measurable behaviors. Responders identify anchor dates to facilitate recall of days in which substances were used.
Conditions Studied
Interventions
- BEHAVIORAL Health Education (HealthEdu)
- BEHAVIORAL Bloom
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2024-10-18 |
| Est. Completion | 2029-05 |
| Phase | NA |
What NCT06395389 shows while recruiting
NCT06395389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 107-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Cannabis Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Health Education (HealthEdu) is the first listed.
NCT06395389 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06395389 about?
NCT06395389 is a clinical study titled "A Brief Intervention for Cannabis Use". The purpose of this study is to compare two brief interventions targeting potentially problematic cannabis use in emerging adults (ages 18-25). Brief interventions are two 40-50 minute sessions separated by 1 week. Eligible emerging adults will complete a detailed cannabis assessment (biological and...
What is the current status of trial NCT06395389?
This trial is currently recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2024-10-18. Estimated completion is 2029-05.
What conditions does trial NCT06395389 study?
This clinical trial studies the following conditions: Cannabis Use Disorder.
What interventions are being tested in trial NCT06395389?
The interventions under investigation include: Health Education (HealthEdu) (BEHAVIORAL), Bloom (BEHAVIORAL).
Who is sponsoring clinical trial NCT06395389?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06395389 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06395389's enrollment target sits among peer trials
62 23rd of 34 higher than 12 of 34 other Cannabis Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
RECRUITING · NA
-
Determining the Effect of Six Weeks of Cannabis Abstinence on Fronto- Striatal fMRI Markers in Adolescents With Cannabis Use Disorder (ABSCAN)
RECRUITING · NA
-
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
RECRUITING · NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
-
RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI